EVOFLOR
ActiveSummary
EVOFLOR has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.1m and a net result of €144,007. Equity is growing by ~5.5% per year across the filed fiscal years. Its solvency ranks better than 80% of 11,011 sector peers (NACE 68, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Directors
Directors
no sitting director read yet, last change in 2026
No directors read yet: 2 of 10 Gazette acts processed. See the function holders in the CBE →
Mandate history
2 people since 2026, 0 in office
- Board
- Day-to-day management
| Name | Functions and periods |
|---|---|
| BELS, An Marleen Rogette |
|
| VONCK, Hans Honoré Anna |
|
Owners and capital
Capital and shareholders
Shareholders according to the acts
Stated in the act
act of 30-12-2025 ↗
- Hans Vonck all shares · 100,00%
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 04-03-2026 Capital increase of €375,000 · to €923,013.21 · no new shares · “zonder creatie van nieuwe aandelen”
- 30-12-2025 Capital stated in the act · €548,013.21 · 15,172 shares